308 related articles for article (PubMed ID: 25064686)
21. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
22. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
23. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
24. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
25. Assessment of intravascular granulomas in testicular seminomas and their association with tumour relapse and dissemination.
Downes MR; Cheung CC; Pintilie M; Chung P; van der Kwast TH
J Clin Pathol; 2016 Jan; 69(1):47-52. PubMed ID: 26193899
[TBL] [Abstract][Full Text] [Related]
26. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
27. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
28. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
30. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
31. Long term outcome and cost in the management of stage I testicular seminoma.
Warde P; Gospodarowicz MK; Panzarella T; Chow E; Murphy T; Catton CN; Sturgeon JF; Moore M; Milosevic M; Jewett MA
Can J Urol; 2000 Apr; 7(2):967-72; discussion 973.. PubMed ID: 11119439
[TBL] [Abstract][Full Text] [Related]
32. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
33. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
[TBL] [Abstract][Full Text] [Related]
34. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
[TBL] [Abstract][Full Text] [Related]
36. Re: Mette Saksø Mortensen, Jakob Lauritsen, Maria Gry Gundgaard, et al. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Eur Urol 2014;66:1172-8.
Aparicio J; Maroto P; Sastre J; Germà JR;
Eur Urol; 2015 May; 67(5):e93-4. PubMed ID: 25477259
[No Abstract] [Full Text] [Related]
37. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
38. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
[TBL] [Abstract][Full Text] [Related]
40. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
